 Granville Lloyd
Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Hyperplasia | 9 | 2024 | 38 | 4.430 |
Why?
| | Lower Urinary Tract Symptoms | 7 | 2024 | 47 | 3.640 |
Why?
| | Erectile Dysfunction | 3 | 2022 | 38 | 1.960 |
Why?
| | Global Burden of Disease | 2 | 2021 | 15 | 1.500 |
Why?
| | Urologists | 2 | 2019 | 17 | 1.340 |
Why?
| | Prostatitis | 2 | 2019 | 18 | 1.330 |
Why?
| | Prostatic Neoplasms | 3 | 2022 | 921 | 1.040 |
Why?
| | Nephrectomy | 4 | 2022 | 150 | 0.860 |
Why?
| | Hypogonadism | 2 | 2022 | 75 | 0.850 |
Why?
| | Urinary Diversion | 1 | 2022 | 11 | 0.850 |
Why?
| | Urinary Retention | 2 | 2019 | 19 | 0.820 |
Why?
| | Carcinoma, Transitional Cell | 1 | 2022 | 54 | 0.810 |
Why?
| | Buschke-Lowenstein Tumor | 1 | 2021 | 1 | 0.780 |
Why?
| | Robotic Surgical Procedures | 1 | 2022 | 86 | 0.750 |
Why?
| | Kidney Neoplasms | 3 | 2022 | 328 | 0.750 |
Why?
| | Soft Tissue Neoplasms | 1 | 2021 | 90 | 0.720 |
Why?
| | Carcinoma, Renal Cell | 1 | 2022 | 168 | 0.700 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2022 | 196 | 0.700 |
Why?
| | Social Determinants of Health | 1 | 2021 | 136 | 0.650 |
Why?
| | Low Back Pain | 1 | 2019 | 95 | 0.600 |
Why?
| | Occupational Diseases | 1 | 2019 | 128 | 0.590 |
Why?
| | Marijuana Smoking | 1 | 2021 | 224 | 0.580 |
Why?
| | Genital Neoplasms, Male | 1 | 2016 | 6 | 0.550 |
Why?
| | Liposarcoma | 1 | 2016 | 26 | 0.540 |
Why?
| | Depression | 2 | 2022 | 1136 | 0.530 |
Why?
| | Hernia, Inguinal | 1 | 2016 | 27 | 0.530 |
Why?
| | Urological Agents | 1 | 2016 | 2 | 0.530 |
Why?
| | Ureteral Calculi | 1 | 2016 | 13 | 0.520 |
Why?
| | Cannabis | 1 | 2022 | 384 | 0.520 |
Why?
| | Urinary Bladder | 2 | 2022 | 163 | 0.520 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2021 | 856 | 0.510 |
Why?
| | Surgeons | 1 | 2019 | 236 | 0.510 |
Why?
| | Adenocarcinoma | 1 | 2021 | 795 | 0.470 |
Why?
| | Hypertension | 1 | 2022 | 1058 | 0.470 |
Why?
| | Male | 22 | 2024 | 55731 | 0.450 |
Why?
| | Brain Neoplasms | 1 | 2021 | 984 | 0.430 |
Why?
| | Penile Prosthesis | 1 | 2012 | 2 | 0.420 |
Why?
| | Urinary Reservoirs, Continent | 1 | 2012 | 4 | 0.420 |
Why?
| | Replantation | 1 | 2012 | 33 | 0.410 |
Why?
| | Sulfonamides | 1 | 2016 | 445 | 0.410 |
Why?
| | Recreation | 1 | 2012 | 23 | 0.400 |
Why?
| | Lubricants | 1 | 2011 | 2 | 0.400 |
Why?
| | Menstrual Hygiene Products | 1 | 2011 | 4 | 0.400 |
Why?
| | Retroperitoneal Space | 1 | 2011 | 15 | 0.390 |
Why?
| | Pelvis | 1 | 2012 | 90 | 0.390 |
Why?
| | Salvage Therapy | 1 | 2012 | 126 | 0.390 |
Why?
| | Pregnancy Complications | 1 | 2016 | 430 | 0.380 |
Why?
| | Veterans | 1 | 2022 | 1238 | 0.380 |
Why?
| | Abdominal Injuries | 1 | 2012 | 95 | 0.370 |
Why?
| | Vena Cava Filters | 1 | 2011 | 50 | 0.370 |
Why?
| | Humans | 27 | 2022 | 115042 | 0.370 |
Why?
| | Foreign Bodies | 1 | 2011 | 99 | 0.350 |
Why?
| | Wounds, Nonpenetrating | 1 | 2012 | 224 | 0.340 |
Why?
| | Urban Population | 1 | 2012 | 401 | 0.340 |
Why?
| | Ergonomics | 2 | 2019 | 23 | 0.340 |
Why?
| | Endoscopy | 1 | 2011 | 246 | 0.330 |
Why?
| | Inflammation | 1 | 2019 | 2485 | 0.320 |
Why?
| | Aged | 8 | 2022 | 19119 | 0.310 |
Why?
| | Practice Patterns, Physicians' | 1 | 2016 | 1177 | 0.290 |
Why?
| | Kidney | 1 | 2012 | 1186 | 0.250 |
Why?
| | Wounds and Injuries | 1 | 2012 | 723 | 0.250 |
Why?
| | Prostate | 2 | 2024 | 157 | 0.240 |
Why?
| | Trichomonas Infections | 1 | 2003 | 7 | 0.230 |
Why?
| | Orchitis | 1 | 2003 | 4 | 0.230 |
Why?
| | Oligospermia | 1 | 2003 | 8 | 0.220 |
Why?
| | Trichomonas vaginalis | 1 | 2003 | 7 | 0.220 |
Why?
| | Biopsy | 3 | 2022 | 1046 | 0.210 |
Why?
| | Follow-Up Studies | 4 | 2019 | 4420 | 0.210 |
Why?
| | Cystectomy | 1 | 2022 | 32 | 0.210 |
Why?
| | Disease Progression | 2 | 2019 | 2389 | 0.200 |
Why?
| | Endocannabinoids | 1 | 2022 | 37 | 0.200 |
Why?
| | Physical Conditioning, Animal | 1 | 2024 | 196 | 0.200 |
Why?
| | Groin | 1 | 2021 | 13 | 0.190 |
Why?
| | Tomography, X-Ray Computed | 5 | 2016 | 2341 | 0.190 |
Why?
| | Quality-Adjusted Life Years | 1 | 2021 | 101 | 0.190 |
Why?
| | Clinical Clerkship | 1 | 2021 | 73 | 0.180 |
Why?
| | Aged, 80 and over | 2 | 2021 | 6357 | 0.170 |
Why?
| | Urinary Tract Physiological Phenomena | 1 | 2019 | 1 | 0.170 |
Why?
| | Insurance Coverage | 1 | 2021 | 201 | 0.170 |
Why?
| | Risk Assessment | 3 | 2019 | 2976 | 0.170 |
Why?
| | Time Factors | 2 | 2021 | 6141 | 0.170 |
Why?
| | Retrospective Studies | 4 | 2022 | 12547 | 0.160 |
Why?
| | Education, Medical, Undergraduate | 1 | 2021 | 169 | 0.160 |
Why?
| | Urinary Tract | 1 | 2019 | 36 | 0.160 |
Why?
| | Education, Medical | 1 | 2021 | 221 | 0.160 |
Why?
| | Chi-Square Distribution | 1 | 2019 | 498 | 0.150 |
Why?
| | Adult | 7 | 2021 | 30656 | 0.150 |
Why?
| | Students, Medical | 1 | 2021 | 272 | 0.150 |
Why?
| | Mice, Inbred C57BL | 2 | 2024 | 4718 | 0.140 |
Why?
| | Global Health | 1 | 2019 | 288 | 0.140 |
Why?
| | Acute Disease | 1 | 2019 | 915 | 0.140 |
Why?
| | Female | 8 | 2022 | 59613 | 0.140 |
Why?
| | Medicare | 1 | 2021 | 666 | 0.130 |
Why?
| | Inflammation Mediators | 1 | 2019 | 476 | 0.130 |
Why?
| | Surveys and Questionnaires | 2 | 2019 | 4631 | 0.130 |
Why?
| | Ultrasonography | 1 | 2019 | 636 | 0.130 |
Why?
| | Middle Aged | 8 | 2022 | 26827 | 0.130 |
Why?
| | Liability, Legal | 1 | 2016 | 38 | 0.130 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 538 | 0.130 |
Why?
| | Malpractice | 1 | 2016 | 37 | 0.130 |
Why?
| | Flank Pain | 2 | 2011 | 5 | 0.120 |
Why?
| | Alcohol Drinking | 1 | 2021 | 655 | 0.120 |
Why?
| | Specialization | 1 | 2016 | 115 | 0.120 |
Why?
| | Aging | 1 | 2024 | 1624 | 0.120 |
Why?
| | Safety | 1 | 2016 | 297 | 0.110 |
Why?
| | Registries | 1 | 2021 | 1763 | 0.110 |
Why?
| | Prevalence | 1 | 2019 | 2255 | 0.110 |
Why?
| | Kidney Pelvis | 1 | 2012 | 20 | 0.100 |
Why?
| | Diagnosis, Differential | 1 | 2016 | 1355 | 0.100 |
Why?
| | Urban Health | 1 | 2012 | 73 | 0.100 |
Why?
| | Neoplasms, Complex and Mixed | 1 | 2012 | 7 | 0.100 |
Why?
| | Treatment Outcome | 3 | 2022 | 9122 | 0.100 |
Why?
| | Postoperative Complications | 1 | 2022 | 2150 | 0.100 |
Why?
| | Venae Cavae | 1 | 2011 | 9 | 0.100 |
Why?
| | Trauma Severity Indices | 1 | 2012 | 111 | 0.100 |
Why?
| | Urination | 2 | 2024 | 40 | 0.100 |
Why?
| | Renal Veins | 1 | 2011 | 9 | 0.100 |
Why?
| | Ureteral Obstruction | 1 | 2012 | 54 | 0.100 |
Why?
| | Stromal Cells | 1 | 2012 | 96 | 0.100 |
Why?
| | Pelvic Neoplasms | 1 | 2011 | 18 | 0.100 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2551 | 0.100 |
Why?
| | Angiomyolipoma | 1 | 2011 | 17 | 0.100 |
Why?
| | Laparoscopy | 2 | 2012 | 387 | 0.100 |
Why?
| | Robotics | 1 | 2012 | 75 | 0.100 |
Why?
| | Radiographic Image Enhancement | 1 | 2011 | 57 | 0.100 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2011 | 52 | 0.090 |
Why?
| | Accidental Falls | 1 | 2012 | 150 | 0.090 |
Why?
| | Obesity | 1 | 2022 | 2524 | 0.090 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2011 | 182 | 0.080 |
Why?
| | United States | 2 | 2022 | 12226 | 0.080 |
Why?
| | Epithelial Cells | 1 | 2012 | 956 | 0.070 |
Why?
| | Incidence | 1 | 2012 | 2318 | 0.070 |
Why?
| | Urination Disorders | 1 | 2005 | 11 | 0.060 |
Why?
| | Autonomic Nervous System | 1 | 2005 | 70 | 0.060 |
Why?
| | Age Factors | 2 | 2024 | 2894 | 0.060 |
Why?
| | Pregnancy | 1 | 2016 | 5520 | 0.060 |
Why?
| | Antitrichomonal Agents | 1 | 2003 | 1 | 0.060 |
Why?
| | Sperm Motility | 1 | 2003 | 26 | 0.060 |
Why?
| | Metronidazole | 1 | 2003 | 19 | 0.060 |
Why?
| | Colorado | 1 | 2012 | 4089 | 0.050 |
Why?
| | Image-Guided Biopsy | 1 | 2022 | 33 | 0.050 |
Why?
| | Frailty | 1 | 2024 | 115 | 0.050 |
Why?
| | Behavior, Animal | 1 | 2024 | 462 | 0.050 |
Why?
| | Insurance, Health | 1 | 2022 | 244 | 0.040 |
Why?
| | Young Adult | 2 | 2012 | 10498 | 0.040 |
Why?
| | Adolescent | 3 | 2012 | 17864 | 0.040 |
Why?
| | Urinary Bladder Neck Obstruction | 1 | 2019 | 20 | 0.040 |
Why?
| | Risk Factors | 1 | 2012 | 8642 | 0.040 |
Why?
| | Cohort Studies | 2 | 2022 | 4904 | 0.040 |
Why?
| | Animals | 3 | 2024 | 31867 | 0.040 |
Why?
| | Mice | 2 | 2024 | 14927 | 0.030 |
Why?
| | Parietal Bone | 1 | 1995 | 11 | 0.030 |
Why?
| | Bone Cysts | 1 | 1995 | 11 | 0.030 |
Why?
| | Epidermal Cyst | 1 | 1995 | 12 | 0.030 |
Why?
| | Curriculum | 1 | 2021 | 843 | 0.030 |
Why?
| | Head Injuries, Closed | 1 | 1995 | 47 | 0.030 |
Why?
| | Clinical Competence | 1 | 2021 | 899 | 0.030 |
Why?
| | Brain Diseases | 1 | 1995 | 127 | 0.030 |
Why?
| | Operative Time | 1 | 2012 | 106 | 0.030 |
Why?
| | Blood Loss, Surgical | 1 | 2012 | 86 | 0.020 |
Why?
| | Constriction, Pathologic | 1 | 2012 | 210 | 0.020 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2012 | 152 | 0.020 |
Why?
| | Surgery, Computer-Assisted | 1 | 2012 | 63 | 0.020 |
Why?
| | Pain, Postoperative | 1 | 2012 | 193 | 0.020 |
Why?
| | Embolization, Therapeutic | 1 | 2011 | 178 | 0.020 |
Why?
| | Length of Stay | 1 | 2012 | 950 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2012 | 1634 | 0.020 |
Why?
| | Hemorrhage | 1 | 2011 | 618 | 0.020 |
Why?
| | Tilt-Table Test | 1 | 2005 | 6 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2012 | 1045 | 0.020 |
Why?
| | Urodynamics | 1 | 2005 | 28 | 0.020 |
Why?
| | Catecholamines | 1 | 2005 | 96 | 0.020 |
Why?
| | Multicenter Studies as Topic | 1 | 2005 | 250 | 0.010 |
Why?
| | Sympathetic Nervous System | 1 | 2005 | 171 | 0.010 |
Why?
| | Multivariate Analysis | 1 | 2005 | 1435 | 0.010 |
Why?
| | Brain Edema | 1 | 1995 | 60 | 0.010 |
Why?
| | Craniotomy | 1 | 1995 | 67 | 0.010 |
Why?
| | Quality of Life | 1 | 2005 | 2359 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 1995 | 3118 | 0.000 |
Why?
|
|
Lloyd's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|